Matches in Nanopublications for { ?s ?p "[Asxl1(+/-) mice also developed mild MDS-like disease, which could progress to MDS/myeloproliferative neoplasm, demonstrating a haploinsufficient effect of Asxl1 in the pathogenesis of myeloid malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP978549.RAWpdtDdIw5MvFkC-7Wg5OjvCK1VyA2Cw4qeJfAcPPKUU130_assertion description "[Asxl1(+/-) mice also developed mild MDS-like disease, which could progress to MDS/myeloproliferative neoplasm, demonstrating a haploinsufficient effect of Asxl1 in the pathogenesis of myeloid malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978549.RAWpdtDdIw5MvFkC-7Wg5OjvCK1VyA2Cw4qeJfAcPPKUU130_provenance.
- assertion description "[Asxl1(+/-) mice also developed mild MDS-like disease, which could progress to MDS/myeloproliferative neoplasm, demonstrating a haploinsufficient effect of Asxl1 in the pathogenesis of myeloid malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Asxl1(+/-) mice also developed mild MDS-like disease, which could progress to MDS/myeloproliferative neoplasm, demonstrating a haploinsufficient effect of Asxl1 in the pathogenesis of myeloid malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1129846.RAArKbpnvn0lNpzOnLjCmsI6gmknKL58jeqmYqibyZ7tY130_assertion description "[Asxl1(+/-) mice also developed mild MDS-like disease, which could progress to MDS/myeloproliferative neoplasm, demonstrating a haploinsufficient effect of Asxl1 in the pathogenesis of myeloid malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1129846.RAArKbpnvn0lNpzOnLjCmsI6gmknKL58jeqmYqibyZ7tY130_provenance.
- NP1129849.RApwzX0yQ8va7ZW1kE5d2fb79_yu-WHHLs488aT37CCf0130_assertion description "[Asxl1(+/-) mice also developed mild MDS-like disease, which could progress to MDS/myeloproliferative neoplasm, demonstrating a haploinsufficient effect of Asxl1 in the pathogenesis of myeloid malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1129849.RApwzX0yQ8va7ZW1kE5d2fb79_yu-WHHLs488aT37CCf0130_provenance.
- NP978673.RA--V9Hewo5xKqwhu_Jlhps19VuAkkGEmUh_WJNsObOtw130_assertion description "[Asxl1(+/-) mice also developed mild MDS-like disease, which could progress to MDS/myeloproliferative neoplasm, demonstrating a haploinsufficient effect of Asxl1 in the pathogenesis of myeloid malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978673.RA--V9Hewo5xKqwhu_Jlhps19VuAkkGEmUh_WJNsObOtw130_provenance.